DANA-FARBER CANCER INSTITUTE

🇺🇸United States
Ownership
-
Established
1947-01-01
Employees
-
Market Cap
-
Website
http://www.dana-farber.org/

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

First Posted Date
2023-03-13
Last Posted Date
2024-02-14
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
110
Registration Number
NCT05765500
Locations
🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

Dana-Farber Cancer Institute at Foxborough, Foxboro, Massachusetts, United States

Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing

First Posted Date
2023-03-08
Last Posted Date
2024-12-05
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
40
Registration Number
NCT05759143
Locations
🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study

First Posted Date
2023-02-23
Last Posted Date
2024-02-20
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
30
Registration Number
NCT05740839
Locations
🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia

First Posted Date
2023-02-21
Last Posted Date
2024-11-08
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
42
Registration Number
NCT05734495
Locations
🇺🇸

Beth Israel Deaconness Medical, Boston, Massachusetts, United States

🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

First Posted Date
2023-02-13
Last Posted Date
2024-10-16
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
28
Registration Number
NCT05726370
Locations
🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

STOP-HER2: Stopping Trastuzumab in HER2+ MBC

First Posted Date
2023-02-09
Last Posted Date
2024-09-30
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
82
Registration Number
NCT05721248
Locations
🇺🇸

Mayo Clinic Hospital Arizona, Phoenix, Arizona, United States

🇺🇸

Georgetown University Medical Center, Washington, District of Columbia, United States

🇺🇸

Mayo Clinical Hospital Florida, Jacksonville, Florida, United States

and more 10 locations

Patient-Centered Surgical Prehabilitation

First Posted Date
2023-02-08
Last Posted Date
2023-03-22
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
25
Registration Number
NCT05715684
Locations
🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

First Posted Date
2023-01-31
Last Posted Date
2024-08-29
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
30
Registration Number
NCT05706766
Locations
🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

A Novel Intervention for Patients With Cancer

First Posted Date
2022-12-08
Last Posted Date
2024-11-22
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
40
Registration Number
NCT05643027
Locations
🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

First Posted Date
2022-11-29
Last Posted Date
2024-10-28
Lead Sponsor
Dana-Farber Cancer Institute
Target Recruit Count
800
Registration Number
NCT05629065
Locations
🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath